Engineered immune cells take aim at Hard-to-Treat lupus

NCT ID NCT06897930

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing a new cell therapy called AZD0120 for adults with severe systemic lupus that hasn't responded well to other treatments. The therapy involves modifying a patient's own immune cells to target and remove harmful cells that drive lupus. The first part of the study checks for safety, and the second part looks at how well it works to control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
NOT_YET_RECRUITING

San Francisco, California, 94143, United States
Research Site
NOT_YET_RECRUITING

Stanford, California, 94304-2201, United States
Research Site
SUSPENDED

Tampa, Florida, 33612, United States
Research Site
NOT_YET_RECRUITING

Atlanta, Georgia, 30322, United States
Research Site
WITHDRAWN

Bethesda, Maryland, 20892, United States
Research Site
NOT_YET_RECRUITING

Boston, Massachusetts, 02115, United States
Research Site
NOT_YET_RECRUITING

St Louis, Missouri, 63110, United States
Research Site
RECRUITING

New York, New York, 10032, United States
Research Site
RECRUITING

Syracuse, New York, 13202-2240, United States
Research Site
NOT_YET_RECRUITING

Chapel Hill, North Carolina, 27599-7280, United States
Research Site
RECRUITING

Charlotte, North Carolina, 28204, United States
Research Site
NOT_YET_RECRUITING

Richmond, Virginia, 23298, United States
Research Site
NOT_YET_RECRUITING

Seattle, Washington, 98104, United States
Research Site
RECRUITING

Seattle, Washington, 98195, United States
Research Site
NOT_YET_RECRUITING

Darlinghurst, 2010, Australia
Research Site
NOT_YET_RECRUITING

Melbourne, 3000, Australia

Conditions

Explore the condition pages connected to this study.

LUPUS ERYTHEMATOSUS, SYSTEMIC